What is Ergoscience?
ErgoScience, Inc. operates at the intersection of human factors engineering and corporate risk management. The company specializes in comprehensive workplace ergonomics and injury prevention programs, specifically targeting the reduction of musculoskeletal disorder (MSD) risks. By integrating job demands analysis, specialized training modules, and proprietary software solutions, ErgoScience provides a robust framework for employers, clinical providers, and insurance carriers to optimize workforce health. Their methodology is rooted in evidence-based practices, which facilitate effective return-to-work programs and early intervention strategies, ultimately driving down insurance costs while simultaneously boosting employee productivity and long-term retention.
How much funding has Ergoscience raised?
Ergoscience has raised a total of $358K across 2 funding rounds:
Debt
$150K
Debt
$208K
Debt (2020): $150K with participation from PPP
Debt (2021): $208K led by PPP
Key Investors in Ergoscience
PPP
Public-Private Partnership
What's next for Ergoscience?
With this late-stage capital, ErgoScience is well-positioned to scale its digital health offerings and expand its footprint within the industrial safety market. The strategic focus will likely shift toward enhancing its software-as-a-service (SaaS) capabilities, allowing for more granular data analytics in injury prevention. By leveraging this financial backing, the company aims to solidify its market dominance, potentially through the integration of advanced predictive modeling to identify ergonomic hazards before they manifest as costly workplace injuries. As the regulatory landscape for occupational safety continues to evolve, ErgoScience remains a critical partner for organizations seeking to modernize their safety infrastructure and improve overall human capital performance.
See full Ergoscience company page
